Edwards Lifesciences Corp — Director's Dealing 2021

May 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-05-07

Reporting Person: Wood Larry L (CVP, TAVR)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-07	Common Stock	F	679.0000	$91.7500	Disposed	367678.5231	Direct
2021-05-10	Common Stock	M	7830.0000	$35.1967	Acquired	375508.5231	Direct
2021-05-10	Common Stock	S	7830.0000	$92.2200	Disposed	367678.5231	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-10	Employee Stock Option (Right to Acquire)	$35.1967	M	7830.0000	Disposed	2023-05-11	Common Stock (7830.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	495.9158	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.

F2: Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator.